Pruritus Therapeutic Market Analysis: Major Players, Lucrative Segments And Top Geographies
6 Jun, 2023
The global pruritus therapeutic market size is expected to grow from $12.09 billion in 2022 to $13.10 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global pruritus therapeutic market size is expected to reach $17.98 billion in 2027 at a CAGR of 8.2%.
Global Pruritus Therapeutic Market Key Driver
The rising prevalence of skin problems is fueling the expansion of pruritus treatment options. Skin conditions are dermatological conditions or skin disorders that affect the skin, such as acne, eczema, skin cancer, psoriasis, and vitiligo. Pruritus treatments are used to treat a variety of skin conditions since pruritus is a common symptom of many of them. For instance, according to World Cancer Research Fund International, a UK-based not-for-profit association related to cancer prevention, in 2020, there was 324,635 new Melanoma of skin cancer cases. Additionally, in January 2023, according to the American Cancer Society, a US-based voluntary organization, In the United States, a projected 97,610 new melanoma cases will be diagnosed in 2023, with about 58,120 in men and 39,490 in women. Therefore, the increasing incidences of skin disorders will drive the pruritus therapeutic market.
Get a sample of the global pruritus therapeutic market reportGlobal Pruritus Therapeutic Market Segments
The global pruritus therapeutic market is segmented:
1) By Type: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Others Types
2) By Disease Type: Atopic Dermatitis Or Eczema, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
3) By Application: External Use, Oral, Injection
4) By End Use: Hospitals, Clinics, Other Uses
5) By Geography: The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global pruritus therapeutic market.
Major Pruritus Therapeutic Industry Players
Allergan PLC, Astellas Pharma Inc., Bristol-Myers Squibb Company, Cipla Inc., Eli Lilly and Company, Galderm, GSK PLC, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Abbott Laboratories, Almirall SA, Eisai Co Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin
Get the full global pruritus therapeutic market reportPruritus Therapeutic Market Overview
Pruritus therapeutic refers to the treatment of pruritus which refer to the uncomfortable feeling that makes a person want to scratch. It can be caused by a variety of factors, which include contact with an allergen, dry skin, pregnancy, and the body's reaction to a medicine.
Pruritus Therapeutic Global Market Report 2023 provides data on the global pruritus therapeutic market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The pruritus therapeutic market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.